On February 26, 2020 Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense reported that Kineta’s management team has been invited to participate at Cowen and Company 40th Annual Health Care Conference in Boston, MA (Press release, Kineta, FEB 26, 2020, View Source;utm_medium=rss&utm_campaign=kineta-invited-to-participate-at-the-cowen-and-company-40th-annual-health-care-conference [SID1234554865]). Shawn Iadonato, Kineta Chief Executive Officer, will provide a corporate overview on Monday, March 2nd at 2:00-2:25 AM, Eastern Time at the Boston Marriott Copley Place.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!